facebook pixel
chevron_right Business
transparent transparent
Takeda to win EU approval for $62 billion Shire deal
BRUSSELS (Reuters) - Japanese drugmaker Takeda Pharmaceutical is set to win conditional EU antitrust approval for its $62-billion bid for London's Shire, the biggest ever overseas acquisition by a Japanese company, two people familiar with the matter said on Friday. Last month, Takeda offered to divest Shire Plc's pipeline compound SHP647 along with some associated rights after the European Commission voiced concerns about the overlap with its own drug for inflammatory bowel disease called Entyvio.
For the best experience use Awesummly app on your Android phone
Awesummly Chrome Extension Awesummly Android App